在沙特阿拉伯探索脏恶性瘤:来自第三级护理中心研究的见解
Ahmed Alasker1,2,3, Turki Rashed Alnafisah1, Mohammad Alghafees1
1College of Medicine, King Saud bin Abdulaziz University for Health Sciences.
Journal of kidney cancer and VHL
|December 25, 2023
概括
这项研究分析了沙特阿拉伯431例细胞癌 (RCC) 病例. 乳头RCC表现出不同的特征,包括更高的血率和更低的存活率,为预后和管理策略提供了信息.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 细胞癌 (RCC) 是一个重要的全球健康问题.
- 了解特定人群中的RCC特征对于有针对性的干预至关重要.
- 沙特阿拉伯的RCC发病率出现了令人担忧的增加.
研究的目的:
- 描述沙特阿拉伯RCC的流行病学和临床特征.
- 分析RCC亚型,Fuhrman等级,瘤特征和整体存活率.
- 确定影响RCC患者预后和管理的因素.
主要方法:
- 在2015年至2023年期间诊断出431名成年RCC患者的回顾性分析.
- 数据收集包括患者人口统计,瘤亚型,Fuhrman等级,瘤大小,阶段和生存率.
- 统计分析以比较不同瘤亚型和患者群体的特征.
主要成果:
- 清晰细胞RCC是最常见的亚型 (72.4%),其次是染色恐惧症 (15.1%) 和乳头癌 (12.5%).
- 乳头RCC在男性中更为常见,并且与更高的血率和更低的存活率有关.
- 在亚型中观察到BMI和Fuhrman等级的显著变化.
结论:
- 沙特阿拉伯的RCC特征显示出不同的模式,特别是在乳头RCC.
- 结果可以指导临床决策,用于预后和患者管理.
- 这些数据支持公共卫生倡议,以应对日益增长的RCC发病率.
相关概念视频
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


